Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01)

This grant encourages the submission of applications that propose to advance research in cancer etiology and early detection biomarkers, utilizing the advantages of the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial. The PLCO Biorepository offers high-quality, prospectively collected, serial pre-diagnostic blood samples from the PLCO screened arm participants, and a onetime collection of buccal cells from the control arm participants. 

Funding: No fixed limit

Duration: 5 years 

LOI (encouraged) due dates: 17.1.16, 16.7.16, 15.1.17, 15.7.17, 15.1.18, 15.7.18

Full application due dates: 17.2.16, 16.8.16, 15.2.17, 15.8.17, 15.2.18, 15.8.18